NCT03324204

Brief Summary

The aim of the trial is to compare the efficacy of extracorporeal shock wave therapy (ESWT) versus neuromuscular training (TR) in reducing pain in women with patellofemoral pain (PFP). Women with PFP will be randomly divided into two therapeutic groups: ESWT and TR. The ESWT group will undergo extracorporeal shock wave therapy to the iliotibial band and tensor fascia latae. The TR group will be treated with neuromuscular training. The women's gait will be analysed and the strength of hip abductors and internal rotators will be measured. Additionally, the women's pain and health status will be assessed with the visual analogue scale and the Lysholm Scale. Outcomes will be registered at baseline, and then at five weeks and at three months post-therapy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 18, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 27, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

October 27, 2017

Status Verified

October 1, 2017

Enrollment Period

3.8 years

First QC Date

July 18, 2017

Last Update Submit

October 24, 2017

Conditions

Outcome Measures

Primary Outcomes (3)

  • Visual Analog Scale is used to assess the subjective Pain.

    The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)

    Outcome measures are obtained at baseline (pre-intervention)

  • Visual Analog Scale is used to assess the subjective Pain.

    The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)

    Outcome measures are obtained, at five weeks after intervention.

  • Visual Analog Scale is used to assess the subjective Pain.

    The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)

    Outcome measures are obtained at three months after intervention

Secondary Outcomes (9)

  • Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.

    Outcome measures are obtained at baseline (pre-intervention)

  • Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.

    Outcome measures are obtained, at five weeks after intervention.

  • Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.

    Outcome measures are obtained at three months after intervention

  • Muscle strength is tested using the Micro Fet Handheld Dynamometer.

    Outcome measures are obtained at baseline (pre-intervention)

  • Muscle strength is tested using the Micro Fet Handheld Dynamometer.

    Outcome measures are obtained, at five weeks after intervention.

  • +4 more secondary outcomes

Study Arms (2)

Neuromuscular Training

EXPERIMENTAL

Each session lasted 30 minutes and consisted of three sets of exercises with 20-30 repetitions. Emphasis is placed on proper knee alignment during exercise. Most of the women exhibit excessive medial rotation and adduction of the femur, resulting in knee valgus. The women will be instructed how to correct their abnormalities using mirrors as visual feedback. All exercises will be completed without pain. If the exercises are too easy, the level of difficulty will be increased individually in accordance with the rehabilitation protocol

Other: Neuromuscular Training

Shock Wave Therapy

ACTIVE COMPARATOR

The ESWT group will will meet the therapist twice in the first week, and once a week after it. ESWT will be applied to the iliotibial band and tensor fascia latae with the following parameters: pressure - 4.5 bar, emission frequency -8 Hz, number of pulses per dose -2,500 per session.

Other: Extracorporeal Shock Wave Therapy (ESWT)

Interventions

Each session lasted 30 minutes and consisted of three sets of exercises with 20-30 repetitions. Emphasis was placed on proper knee alignment during exercise. Most of the women exhibited excessive medial rotation and adduction of the femur, resulting in knee valgus, although knee varus was also observed. The women were instructed how to correct their abnormalities using mirrors as visual feedback. All exercises were completed without pain. If the exercises were too easy, the level of difficulty was increased individually in accordance with the rehabilitation protocol

Neuromuscular Training

ESWT will be applied to the iliotibial band and tensor fascia latae muscle with the following parameters: pressure - 4.5 bar, emission frequency -8 Hz, number of pulses per dose -2,500 per session

Shock Wave Therapy

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Knee pain for more than three months greater than three on the visual analogue scale (VAS) during at least two out of four typical activities:
  • ascending or descending the stairs,
  • prolonged sitting with flexed knee,
  • running or jumping,
  • squatting or kneeling.

You may not qualify if:

  • Orthopaedic diagnosis other than PFP.
  • Patients with neurological disorders, history of injury or operations within the symptomatic leg, rheumatoid disease, or pregnancy were also excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland

Katowice, Silesian Voivodeship, 40-752, Poland

RECRUITING

MeSH Terms

Conditions

Patellofemoral Pain Syndrome

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Mgdalena Dabrowska-Galas, PhD

    Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland

    STUDY CHAIR

Central Study Contacts

Tomasz Michalski

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 18, 2017

First Posted

October 27, 2017

Study Start

August 1, 2014

Primary Completion

June 1, 2018

Study Completion

January 1, 2019

Last Updated

October 27, 2017

Record last verified: 2017-10

Locations